✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Aarti Drugs Ltd.

AARTIDRUGS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹4,791 Cr.
P/E
25.37

Aarti Drugs Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
4,791 Cr
PE
PE
25.37
Prom Holding
Prom Holding
55.22 %
ROE (%)
ROE (%)
12.28
ROCE (%)
ROCE (%)
14.43
Div Yield (%)
Div Yield (%)
0.19
Sales
Sales
2,422 Cr
OPM (%)
OPM (%)
12.23 %
Debt to Equity
Debt to Equity
0.45
View more
Edit Ratio's
About
Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R… Read more
Low
312
52W Range
High
564
  • Aarti Drugs
  • Supriya Lifescience
  • IOL Chem & Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    locked
    Select a Metric
    • APIs Production Capacity (MTPA)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Nizoral
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Abbott India Ltd.
    • Alembic Pharmaceuticals Ltd.
    • Cipla Ltd.
    • Indoco Remedies Ltd.
    • Kopran Ltd.
    FAQs on Aarti Drugs Ltd. Business

    Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.

    Aarti Drugs major competitors are Supriya Lifescience, IOL Chem & Pharma, Solara Active Pharma, Morepen Laboratories, SMS Pharmaceuticals, Hester Biosciences, Shilpa Medicare.
    Market Cap of Aarti Drugs is ₹4,791 Crs.
    While the median market cap of its peers are ₹3,257 Crs.

    Aarti Drugs seems to be less financially stable compared to its competitors.
    Altman Z score of Aarti Drugs is 4.52 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Aarti Drugs Ltd.
    View the discussion on ValuePickr
    AARTI DRUGS vs AARTI PHARMALABS | Which is Best? - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material